Similar to the in vivo model, elevated levels of activated MEK1/2, ATF-2 and STAT3 (Tyr705 and Tyr727) were observed in the RJenvC1 tumor cells, with no difference in STAT5, mTOR or p70S6K activation. The gene discussed is MAP2K1; the disease is neoplasm.